SCHEMBL25681729

SCHEMBL25681729

CB(C)C1CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7941599 0.77 — —
SCHEMBL20939371 0.67 CHRM2 (0.47) —
SCHEMBL19992145 0.67 CHRM2 (0.47) —
SCHEMBL11014798 0.65 — —
SCHEMBL292798 0.65 — —
SCHEMBL2274269 0.65 CHRM2 (0.45) —
SCHEMBL88667 0.65 — —
SCHEMBL254419 0.65 — —
SCHEMBL20384062 0.65 CHRM2 (0.45) —
Ammonia Solution, Strong SCHEMBL1561055 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 — — WO disclosed
Send feedback